Enhanced photothermal and chemotherapy of pancreatic tumors by degrading the extracellular matrix

Colloids Surf B Biointerfaces. 2023 Jan:221:113010. doi: 10.1016/j.colsurfb.2022.113010. Epub 2022 Nov 8.

Abstract

The degradation of extracellular matrix (ECM) to increase drug permeability is an attractive approach to enhancing pancreatic cancer therapy efficiency. Herein, polypyrrole nanoparticles (PPy NPs) were prepared by a template-guided chemical oxidation method. These PPy NPs with abundant surface pores were used to load the anticancer drug doxorubicin (DOX). In order to intelligently control the DOX release, PPy/DOX NPs were further entrapped with a thermoresponsive ligand, lauric acid (LA), to form PPy-LA/DOX NPs. Bromelain (BL) was then grafted onto the surface of PPy-LA NPs or PPy-LA/DOX NPs through an amidation reaction with the carboxyl group of LA. It was found that the DOX release of PPy-LA/DOX NPs was pH and temperature responsive, reaching a maximum amount of 85.9% within 48 h at pH = 5.4 and 50 °C. Moreover, it was demonstrated that the resultant PLB (PPy-LA-BL) NPs could efficiently hydrolyze the collagen in ECM and enhance the permeability of DOX to the pancreatic tumor. Remarkably, PLB NPs not only featured admirable photothermal conversion but also exhibited obvious photoacoustic imaging capability, which enabled imaging-guided enhanced tumor ablation. This study is anticipated to provide a feasible strategy to improve the permeability of nanoparticles to tumors.

Keywords: Bromelain; Pancreatic tumor; Photoacoustic imaging; Photothermal.

MeSH terms

  • Doxorubicin / pharmacology
  • Extracellular Matrix
  • Humans
  • Pancreatic Neoplasms* / drug therapy
  • Polymers*
  • Pyrroles

Substances

  • Polymers
  • Pyrroles
  • Doxorubicin